Russia. Strategy approved for pharmaceutical support in Russia until 2025

Russian Government Order No. 66 dated 13.02.2013 has approved the Strategy for pharmaceutical support in Russia until 2025. The strategy defines the top-priority social and economic objectives of pharmaceutical support to the Russian population in the long term (see also KPMG Pharma Bulletin, Issue #29).

The aim of the strategy is to increase the availability of high-quality, effective and safe pharmaceuticals which meet the requirements of both citizens and the healthcare system, and which are based on the creation of a sustainable and balanced system of pharmaceutical support.

Source: http://goo.gl/smQlX